Tesla (TSLA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Tesla's (NASDAQ: TSLA | TSLA Price Prediction) Q1 2026 results gave bulls something to cheer about, but the stock remains stuck in a choppy range heading into summer.
Semiannual earnings reporting tries to “fix” a problem that the market's success stories have already solved.
Wall Street's smart money is openly fractured on Tesla (NASDAQ: TSLA | TSLA Price Prediction).
Tesla delivered strong Q1'26 results, achieving its highest gross margins in over a year and robust free cash flow growth. TSLA is accelerating its transition towards AI and robotics, with mass production of the Optimus Humanoid targeted for H2'26 and significant investments in SpaceX and AI hardware. Despite a revenue miss, TSLA expanded its gross margins and demonstrated 117% year-over-year free cash flow growth, reinforcing its premium valuation.
TSLA slides despite a Q1 earnings beat as a $5B capex hike tied to AI and Robotaxi ambitions rattles sentiment, pushing investors toward ETF consideration.
Tesla is primed to pour more into capital spending in 2026 than it has in any other year on record as it pursues a series of high-risk, high-reward opportunities. One analyst thinks the company's newest disclosures around this spending are a worrisome sign.
German research house DZ Bank lifted its rating on Tesla (NASDAQ:TSLA | TSLA Price Prediction) from Sell to Hold with a $385 price target, a two-notch shift that signals the firm's bearish stance on the EV maker is finally softening.
Tesla delivered a Q1 double-beat, but shares fell as high capex spending and cautious AI scaling tempered optimism. TSLA maintains a "Buy" rating, with growth-adjusted valuation attractive despite technical weakness and increased capex guidance to $25 billion. Key forward drivers include FSD monetization, Robotaxi and Optimus launches, and production of Cybercab, Semi, and Megapack 3 by 2026.
Tesla, Inc. shows early FY 2026 trends mirroring recent previous years, with an expectation of flat-to-weak revenue and a 48% net income reduction. TSLA's operating expenses are set to grow at least 20%, while free cash flow turned positive at $1.44 billion but is stated to be negative for the rest of the year. Major strategic initiatives include humanoid robots, AI compute, chip fabrication, and battery manufacturing, signaling bold but risky bets beyond core automotive.
Tesla, Inc. remains a Buy in my books, but the investment case now hinges on high-risk, high-reward capex in AI, robotics, and energy. TSLA's $25B FY26 capex plan, well above expectations, will drive negative cash flow and compress earnings before potential expansion post-2026. Growth vectors, including Optimus and Robotaxi are future-oriented, with current spending outpacing near-term revenue visibility and timelines subject to delay.
The high-profile trial between Elon Musk and Sam Altman is scheduled to begin on Monday with jury selection. In his $134 billion lawsuit, Musk claimed that OpenAI, Altman and the company's president, Greg Brockman, reneged on a vow they made to keep the AI lab a nonprofit in perpetuity.